How 30 minutes of daily activity can lower blood sugar and reduce medication dependence
Walking is often underestimated. It improves circulation, helps muscles absorb glucose, and reduces stress. But doing only one…
Ozempic just got cheap enough to change the world
By now, Ozempic needs no introduction in America. One in 8 American adults now takes a GLP-1 drug…
6 drugs invented for one thing — but now treat another
Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if…
Surge of generic weight-loss drugs triggers price war in India
Open this photo in gallery: Obesity doctor and consultant Swati Pradhan explains the Mounjaro GLP-1 self-injectable device at…
All about new ‘triple-G’ drug that’s helped patients lose a quarter of their body weight
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight…
At 48, I was told I was prediabetic
The idea that fitness should slow down in mid-life might be tempting – but it is also one…
Why milk choices matter: Silent sugar problem affecting Filipino kids today
MANILA, Philippines — The number of people suffering from lifestyle diseases is growing. Perhaps this is because of…
Why milk choices matter: Silent sugar problem affecting Filipino kids today
MANILA, Philippines — The number of people suffering from lifestyle diseases is growing. Perhaps this is because of…
Dr Michael Mosley says one meal time change could ‘reduce the risk of diabetes’
Dr Michael Mosley, the pioneer behind intermittent fasting, says his dinner time change could also lower the chances…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
GLP-1 RA generics have arrived. Could we buy semaglutide made for just $4?
Semaglutide is now generic. Just not in Australia. But in China, Brazil and Canada, generic drug makers are…
The Unexpected Mental Health Effect of GLP-1 Medications
By now, you can probably list off the potential perks of going on a GLP-1 receptor agonist like…